Jin Hong

409 total citations
23 papers, 229 citations indexed

About

Jin Hong is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Jin Hong has authored 23 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 13 papers in Cancer Research and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Jin Hong's work include Breast Cancer Treatment Studies (10 papers), Cancer Immunotherapy and Biomarkers (6 papers) and HER2/EGFR in Cancer Research (4 papers). Jin Hong is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Cancer Immunotherapy and Biomarkers (6 papers) and HER2/EGFR in Cancer Research (4 papers). Jin Hong collaborates with scholars based in China, Switzerland and United States. Jin Hong's co-authors include Xiaosong Chen, Kunwei Shen, Jianrong He, Weiguo Chen, Jiayi Wu, Yafen Li, Ou Huang, Xiaochun Fei, Li Zhu and Renhong Huang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Frontiers in Immunology.

In The Last Decade

Jin Hong

22 papers receiving 227 citations

Peers

Countries citing papers authored by Jin Hong

Since Specialization

Citations

This map shows the geographic impact of Jin Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Hong more than expected).

Fields of papers citing papers by Jin Hong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Hong. The network helps show where Jin Hong may publish in the future.

Co-authorship network of co-authors of Jin Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Jin Hong. A scholar is included among the top collaborators of Jin Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin Hong. Jin Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Carboplatin-resistance-related DNA damage repair prognostic gene signature and its association with immune infiltration in breast cancer 2025 ·Frontiers in Immunology ·Shuwen Dong, Anqi Li, Ruijun Pan, Jin Hong, Zheng Wang, Kunwei Shen	1
2	Trastuzumab, pertuzumab and nab-paclitaxel plus pyrotinib or not in neoadjuvant treatment of HER2-positive breast cancer: A multi-center, randomized, open-label, phase II study. 2024 ·Journal of Clinical Oncology ·Xiaosong Chen, Jiahui Huang, Yiwei Tong, (unknown), Jing Yu, Weiqi Gao, (unknown), Jin Hong, Jiayi Wu, Ou Huang, Jianrong He, Weiguo Chen, Yafen Li, Kunwei Shen	0
3	Targeting glutamine metabolic reprogramming of SLC7A5 enhances the efficacy of anti-PD-1 in triple-negative breast cancer 2023 ·Frontiers in Immunology ·Renhong Huang, Han Wang, Jin Hong, Jiayi Wu, Ou Huang, Jianrong He, Weiguo Chen, Yafen Li, Xiaosong Chen, Kunwei Shen, Zheng Wang	24
4	Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple-negative breast cancer progression and enhances the efficacy of anti-PD-1 immunotherapy 2023 ·Cell Death and Disease ·Renhong Huang, Zheng Wang, Jin Hong, Jiayi Wu, Ou Huang, Jianrong He, Weiguo Chen, Yafen Li, Xiaosong Chen, Kunwei Shen	36
5	Association of tumor immune microenvironment profiling and 21-gene recurrence assay in early breast cancer patients 2022 ·European journal of medical research ·Yiwei Tong, Jiahui Huang, (unknown), Jing Yu, Xu Zhang, Zheng Wang, Jin Hong, Weiqi Gao, Jiayi Wu, Min Ji, Kunwei Shen, Xiaosong Chen	4
6	Neoadjuvant docetaxel, epirubicin, and cyclophosphamide with or without metformin in breast cancer patients with metabolic abnormality: results from the randomized Phase II NeoMET trial 2022 ·Breast Cancer Research and Treatment ·Jiahui Huang, Yiwei Tong, Jin Hong, Ou Huang, Jiayi Wu, Jianrong He, Weiguo Chen, (unknown), Xiaosong Chen, Kunwei Shen	11
7	The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial 2022 ·Cancers ·(unknown), Jiayi Wu, Cai‐Jin Lin, Shuning Ding, Shuangshuang Lu, Fang Yan, Jiahui Huang, Jin Hong, Weiqi Gao, (unknown), Xiaosong Chen, Ou Huang, Jianrong He, Weiguo Chen, (unknown), Kunwei Shen, Li Zhu	4
8	Efficacy of adjuvant chemotherapy stratified by age and the 21-gene recurrence score in estrogen receptor-positive breast cancer 2021 ·BMC Cancer ·Jing Yu, Cai‐Jin Lin, Jiahui Huang, Jin Hong, Weiqi Gao, (unknown), Lin Lin, Xiaosong Chen, Ou Huang, Jianrong He, Li Zhu, Weiguo Chen, (unknown), Jiayi Wu, Kunwei Shen	2
9	Association of tumor‐infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancer 2021 ·Cancer Medicine ·Jin Hong, (unknown), Xiaochun Fei, Xiaosong Chen, Kunwei Shen	16
10	Abstract PS4-28: Efficacy of adjuvant chemotherapy stratified by age and the 21 gene recurrence score in estrogen receptor positive breast cancer 2021 ·Cancer Research ·Jing Yu, Cai‐Jin Lin, Jiahui Huang, Jin Hong, Weiqi Gao, (unknown), Hui Wang, Ou Huang, Xiaosong Chen, Jianrong He, Li Zhu, Weiguo Chen, Yafen Li, Kunwei Shen, Jiayi Wu	1
11	Comparison of the Distribution Pattern of 21-Gene Recurrence Score between Mucinous Breast Cancer and Infiltrating Ductal Carcinoma in Chinese Population: A Retrospective Single-Center Study 2020 ·Cancer Research and Treatment ·Jiayi Wu, Shuning Ding, Lin Lin, Xiaochun Fei, Cai‐Jin Lin, (unknown), (unknown), Jiahui Huang, Jin Hong, Weiqi Gao, (unknown), Hui Wang, Ou Huang, Xiaosong Chen, Jianrong He, (unknown), Kunwei Shen, Weiguo Chen, Li Zhu	7
12	A prospective, randomized study of Toremifene vs. tamoxifen for the treatment of premenopausal breast cancer: safety and genital symptom analysis 2020 ·BMC Cancer ·Jin Hong, Jiahui Huang, Lili Shen, (unknown), Weiqi Gao, Jiayi Wu, Ou Huang, Jianrong He, Li Zhu, Weiguo Chen, Yafen Li, Xiaosong Chen, Kunwei Shen	17
13	Early response and pathological complete remission in Breast Cancer with different molecular subtypes: a retrospective single center analysis 2020 ·Journal of Cancer ·Jin Hong, Jiayi Wu, Ou Huang, Jianrong He, Li Zhu, Weiguo Chen, Yafen Li, Xiaosong Chen, Kunwei Shen	11
14	<p>A high absolute lymphocyte count predicts a poor prognosis in HER-2- positive breast cancer patients treated with trastuzumab</p> 2019 ·Cancer Management and Research ·Jin Hong, Xiaosong Chen, Weiqi Gao, (unknown), Jiayi Wu, Ou Huang, Jianrong He, Li Zhu, Weiguo Chen, Yafen Li, Xiaochun Fei, Lin Lin, Kunwei Shen	14
15	21‑gene recurrence score influences the chemotherapy decision for patients with breast cancer of different luminal subtypes 2019 ·Oncology Letters ·Wei Wang, Lin Lin, Xiaochun Fei, Jin Hong, Weiqi Gao, (unknown), Jiayi Wu, Ou Huang, Jianrong He, (unknown), Li Zhu, Weiguo Chen, Xiaosong Chen, Kunwei Shen	2
16	Distribution and Clinical Utility of the 21-gene Recurrence Score in Pure Mucinous Breast Cancer Patients: a case-control study 2018 ·Journal of Cancer ·Wei Wang, Xiaosong Chen, Lin Lin, Xiaochun Fei, David Garfield, Jin Hong, Weiqi Gao, (unknown), Jiayi Wu, Ou Huang, Jianrong He, (unknown), Li Zhu, Weiguo Chen, Kunwei Shen	10
17	Elevated preoperative neutrophil-to-lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancer 2015 ·Tumor Biology ·Jin Hong, Yan Mao, Xiaosong Chen, Li Zhu, Jianrong He, Weiguo Chen, Yafen Li, Lin Lin, Xiaochun Fei, Kunwei Shen	36
18	An analysis of the long-term therapeutic effect of the integrated therapy of traditional Chinese medicine and radiotherapy on abdominal malignant tumor. 2005 ·PubMed ·Jin Hong, (unknown), Yanping Chen, (unknown), Wen Liu	2
19	Treatment of impotence by point-through-point acupuncture plus Tuina 2005 ·Journal of Acupuncture and Tuina Science ·Jin Hong, Lirong Zhang, (unknown)	2
20	A Randomized, Placebo, Controlled, Double Blind Trial Study on IL-8 Monoclonal Antibody Cream in the Treatment of Psoriasis Vulgaris 2001 ·The Chinese Journal of Clinical Pharmacology ·Jin Hong	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact